These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38573778)

  • 1. Engineering Nanozymes for Tumor Therapy via Ferroptosis Self-Amplification.
    Liu S; Wei Y; Liang Y; Du P; Lei P; Yu D; Zhang H
    Adv Healthc Mater; 2024 Jul; 13(19):e2400307. PubMed ID: 38573778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-responsive cascade enzyme-like catalytic nanoassembly for ferroptosis amplification and nanozyme-assisted mild photothermal therapy.
    Gu D; Zhu L; Wang Z; Zhi X; Liu M; Ge S; Sun B; Liang X; Wu H; Wang Y
    Acta Biomater; 2024 Oct; 187():366-380. PubMed ID: 39209133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH Oxidase-Like Nanozyme for High-Efficiency Tumor Therapy Through Increasing Glutathione Consumption and Blocking Glutathione Regeneration.
    Han D; Ding B; Zheng P; Yuan M; Bian Y; Chen H; Wang M; Chang M; Kheraif AAA; Ma P; Lin J
    Adv Healthc Mater; 2024 Apr; 13(11):e2303309. PubMed ID: 38214472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese-induced Photothermal-Ferroptosis for Synergistic Tumor Therapy.
    Chen K; Sun R; Guan Y; Fang T; Tao J; Li Z; Zhang B; Yu Z; Tian J; Teng Z; Wang J
    J Control Release; 2024 Aug; 372():386-402. PubMed ID: 38909699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.
    Yu Z; Wang C; Ye Y; Wang S; Jiang K
    J Nanobiotechnology; 2024 May; 22(1):253. PubMed ID: 38755600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H
    Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W
    Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
    Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
    Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
    Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
    Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous NiB@IrO
    Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
    Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu
    Chen W; Xie W; Gao Z; Lin C; Tan M; Zhang Y; Hou Z
    Adv Sci (Weinh); 2023 Nov; 10(33):e2303694. PubMed ID: 37822154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Carbon Quantum Dots Precisely Trigger Ferroptosis in Cancer Cells through Antioxidant Inhibition Synergistic Nanocatalytic Activity.
    Jin N; Wang Z; Yin C; Bu W; Jin N; Ou L; Xie W; He J; Lai X; Shao L
    ACS Appl Mater Interfaces; 2024 Jul; 16(29):37456-37467. PubMed ID: 39007694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
    Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.
    Zhu L; Dai Y; Gao L; Zhao Q
    Int J Nanomedicine; 2021; 16():4559-4577. PubMed ID: 34267513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2D Catalytic Nanozyme Enables Cascade Enzyodynamic Effect-Boosted and Ca
    Wang Z; Wang X; Dai X; Xu T; Qian X; Chang M; Chen Y
    Adv Mater; 2024 Jun; 36(24):e2312316. PubMed ID: 38501540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembly of 2D Polyphthalocyanine in Lysosome Enables Multienzyme Activity Enhancement to Induce Tumor Ferroptosis.
    Rong M; Liu J; Lu L
    Adv Healthc Mater; 2024 Jun; 13(15):e2400325. PubMed ID: 38364772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bimetallic Polymerization Network for Effective Increase in Labile Iron Pool and Robust Activation of cGAS/STING Induces Ferroptosis-Based Tumor Immunotherapy.
    Wang Z; Zhou P; Li Y; Zhang D; Chu F; Yuan F; Pan B; Gao F
    Small; 2024 May; 20(20):e2308397. PubMed ID: 38072786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
    Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
    J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.
    Xie X; Li Z; Tang H; Zhang Y; Huang Y; Zhang F; You Y; Xu L; Wu C; Yao Z; Peng X; Zhang Q; Li B
    Acta Biomater; 2024 Jul; 183():292-305. PubMed ID: 38838903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy.
    Bai J; Zhang X; Zhao Z; Sun S; Cheng W; Yu H; Chang X; Wang B
    Small; 2024 Oct; 20(40):e2400326. PubMed ID: 38813723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
    Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
    J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.